Amgen (AMGN) Change in Acquisitions & Divestments (2009 - 2023)

Amgen's Change in Acquisitions & Divestments history runs 15 years deep, the most recent figure standing at $573.0 million for Q4 2023.

• In Q4 2023, Change in Acquisitions & Divestments fell 48.84% year-over-year to $573.0 million; the TTM figure through Sep 2024 stood at $573.0 million (down 65.69% YoY), while the FY2023 annual figure was $1.1 billion, changed 0.27% from the prior year.
• Change in Acquisitions & Divestments for Q4 2023 stood at $573.0 million, up from -$574.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $10.5 billion in Q1 2019, with the low at -$3.5 billion in Q4 2021.
• The 5-year median for Change in Acquisitions & Divestments is $1.6 billion (2020), against an average of $2.0 billion.
• Peak annual rise in Change in Acquisitions & Divestments reached 3438.94% in 2021, while the deepest fall reached 272.49% in 2021.
• Amgen's Change in Acquisitions & Divestments stood at $2.1 billion in 2019, then fell by 3.04% to $2.0 billion in 2020, then plunged by 272.49% to -$3.5 billion in 2021, then soared by 131.78% to $1.1 billion in 2022, then slumped by 48.84% to $573.0 million in 2023.
• Business Quant data shows AMGN's Change in Acquisitions & Divestments at $573.0 million in Q4 2023, -$574.0 million in Q2 2023, and $1.1 billion in Q1 2023.